NCT00216918View on ClinicalTrials.gov

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

June 30, 2006

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine Hydrochloride

Trial Locations (1)

G1R 2W8

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Québec

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00216918 - Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. | Biotech Hunter | Biotech Hunter